http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102302462-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22db613d77ea6989809fd1138eb6a30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| filingDate | 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f4464f2d60478fe76c013c7f1ab4edb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_955ffdeabce7ab9590cce1d0e72b01f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ad00095a03e4c592620cc0848759696 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4316a879b89690c98c5177158b72faf4 |
| publicationDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102302462-B |
| titleOfInvention | Gemcitabine hydrochloride lyophilized preparation |
| abstract | The present invention discloses a gemcitabine hydrochloride lyophilized preparation. The lyophilized preparation comprises, by weight, 20-70 parts of gemcitabine hydrochloride, 15-60 parts of a lyoprotectant and 0.005-0.5 parts of an antioxidant. Compared to the prior art, with the gemcitabine hydrochloride lyophilized preparation provided by the present invention, the problem of the stability of the gemcitabine hydrochloride is solved; the product quality is ensured; the risk of drug using is reduced; the preparation process is simple, the cost is low; and the preparation is suitable for the industrial production, and has practical value. |
| priorityDate | 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.